Sernova Biotherapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is November - October.

Millions EUR. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jan '26 Jan 8, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	2016 - 2020
Market Capitalization	30	37	54	166	174	228	Upgrade
Market Cap Growth	-39.57%	-31.80%	-67.65%	-4.44%	-23.62%	539.72%	Upgrade
Enterprise Value	33	40	51	145	143	207	Upgrade
Last Close Price	0.08	0.09	0.16	0.52	0.60	0.86	Upgrade
PB Ratio	-1.95	-2.36	-6.28	19.49	4.93	11.63	Upgrade
P/TBV Ratio	-	-	-	19.99	4.98	11.93	Upgrade
Debt / Equity Ratio	-0.19	-0.19	-0.04	0.01	0.01	0.01	Upgrade
Quick Ratio	0.02	0.02	0.32	2.17	10.74	19.19	Upgrade
Current Ratio	0.02	0.02	0.32	2.19	10.78	19.19	Upgrade
Return on Equity (ROE)	-	-	-	-129.72%	-64.54%	-43.25%	Upgrade
Return on Assets (ROA)	-226.48%	-226.48%	-133.56%	-67.87%	-37.59%	-24.39%	Upgrade
Return on Capital (ROIC)	-	-	-14992.87%	-83.63%	-40.53%	-26.03%	Upgrade
Return on Capital Employed (ROCE)	62.50%	62.50%	253.60%	-323.60%	-51.80%	-24.50%	Upgrade
Earnings Yield	-32.25%	-26.57%	-39.58%	-15.99%	-10.41%	-2.13%	Upgrade
FCF Yield	-	-18.41%	-23.23%	-12.48%	-6.29%	-2.10%	Upgrade
Buyback Yield / Dilution	-6.95%	-6.95%	-1.19%	-10.87%	-11.43%	-24.45%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.